Bluebird Ventures
Bluebird Ventures is a venture capital firm focused on creating and investing in life sciences companies that have a significant impact on the world. Founded by Jeff Bird, the firm leverages his extensive experience in the life sciences sector to support innovative startups. Bluebird Ventures is committed to advancing medical science by partnering with passionate and committed founders and entrepreneurs.
Bluebird Ventures
C/O Sutter Hill Ventures 755 Page Mill Road, Suite A200 Palo Alto CA 94304
Portfolio
Epirium Bio is developing therapeutics that stimulate muscle growth and strength, with clinical data in degenerative muscle disease indications.
#Mitochondrial Biogenesis
Developed an antibody against CD47, went public in 2018, acquired by Gilead in 2019 for $4.9 billion.
#Immuno-Oncology
Focuses on gene therapy for major medical indications including Diabetes and Ophthalmologic diseases.
#Gene Therapy
Developing peptide-based cytokine activating drugs for cancer treatment.
#Cytokine Activating Cancer Drugs
Disrupting RNA Therapeutics manufacturing with a 'GMP factory in a box'.
#RNA Therapeutics
Developing a medical device to treat Congestive Heart Failure using an innovative implantable intravascular pump.
#Congestive Heart Failure
Key People
Founder and Managing Director